Skip to content

GYNECOLOGY SOCIETY DEVELOPMENT

Active Private limited company (pre-2019)founded 2008active for 18 yearsRoute de Hottleux 112/1, 4950 WaimesKBO/BCE: BE 0807.537.767

Lifetime

17 annual accounts with figures on one time axis
peak of €97,979 in 2017
€34,411▼ 24.2%
lowest -€58,469 in 2023
€3,111▼ 82.9%
peak of €1,930 in 2009
-€37,543▲ €3,111
€78,832▲ 47.0%
peak of 0.5 FTE in 2018
-not published
Board1 name since 2008
1 director
Documentsfilings and deeds
15-06-202615 days late
2025micro format
Gross margin from €45,419 to €34,411Result from €18,149 to €3,111Debts from €53,618 to €78,832Investments €32,986

Key points

from the 2025 annual accounts

Equity

-€37,543
202020212022202320242025

Debts exceed assets in financial year 2025.

Turnover

≈ €110,000 estimated

The micro format states no turnover.

Debts

€78,832 191% of the balance sheet
Financial debts 31%Suppliers 9%Taxes and wages 1%Other 60%

Of this, €54,599 falls due within a year.

Investments

€32,986 3.6 times depreciation
20212022202320242025

Green is investment, beige is depreciation.

Filings

17 annual accounts since 2009
deadline2010201520202025

Six of the last ten came late. The 2023 accounts came in latest, 47 days after the end of the period.

Position in the sector

-90.9%

Lower solvency than 95% of companies in human health. The sector median is 63.0%, over 21,385 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 3,634 companies had the same profile as GYNECOLOGY SOCIETY DEVELOPMENT has now. Each dot stands for 10 companies, two years later.

91.9%
were still trading
4.8%
stopped another way
3.2%
went bankrupt
  • Micro
  • 10 to 20 years old
  • negative equity
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 3,634 companies, not a prediction for GYNECOLOGY SOCIETY DEVELOPMENT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 03-11-2008
  • 186 sharesdeed of 12-11-2008
Board & ownership

Recent changes

Registered office moved from Boussire to Waimes The registered office moved from Rue des Hêtres 5 à 4960 Boussire to Route de Hottleux 112/1 4950 Waimes · Board meeting of 23-09-2025 · Gazette deed
Registered office moved from Waimes to Montigny-le-Tilleul The registered office moved from Route de Hottleux 112/1 à 4950 Waimes to Rue de la Croix Rouge 36 6110 Montigny-le-Tilleul · Board meeting of 28-09-2023 · Gazette deed
First establishment G.S.D., Rue de Hottleux 112, Waimes
Registered-office move General meeting of 29-06-2010 · Gazette deed
All 28 events

Comparable companies

same main activity, similar in size and age
Company
GYNECOLOGY SOCIETY DEVELOPMENT Malmedy €41,288 €34,411 -90.9% -
Dokter Paul Boon, Neurologie Knokke-Heist €45,003 €36,338 -162.7% 0
PEDIAPLAN Lasne €38,080 €28,916 24.0% -
DR. LUC DE CLERCQ - REUMATOLOGIE Antwerp €32,611 €40,695 56.5% -
CABINET DE PSYCHOLOGIE GARCET Spa €63,792 €32,101 63.5% -
DR. HERMANS Lier €41,135 €35,082 66.4% -
CYDAR, Cabinet Médical du Dr. J. Rafati Woluwe-Saint-Lambert €53,980 €41,147 81.2% -

These companies have the same main activity as GYNECOLOGY SOCIETY DEVELOPMENT: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €32,600 and €63,800, founded between 2006 and 2014.

Official details

Source: KBO
Status
Active since 03-11-2008Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.204.310.1524950 Waimes, since 25-11-2011
Financial year end
31 October
Peppol
Not found in the Peppol Directory
Company details

Annual accounts to 31-10-2025

€41,288▲ 218%
Employeeson 31-10-2025
1=
Filing
Filed on 15-06-2026
Financials

Insights on GYNECOLOGY SOCIETY DEVELOPMENT

GYNECOLOGY SOCIETY DEVELOPMENT files the micro format. That format states no turnover. The gross margin rose from €954 in 2009 to €34,411 in 2025.

The balance sheet grew most in 2010 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about GYNECOLOGY SOCIETY DEVELOPMENT

What is the company number of GYNECOLOGY SOCIETY DEVELOPMENT?
The company number of GYNECOLOGY SOCIETY DEVELOPMENT is 0807.537.767. The VAT number is the same number with BE in front: BE 0807.537.767.
Where is GYNECOLOGY SOCIETY DEVELOPMENT based?
The registered office is at Boussire - Rue des Hêtres 5, 4960 Malmedy.Company details
What does GYNECOLOGY SOCIETY DEVELOPMENT do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of GYNECOLOGY SOCIETY DEVELOPMENT?
GYNECOLOGY SOCIETY DEVELOPMENT is a private limited company (pre-2019) (BVBA).
When was GYNECOLOGY SOCIETY DEVELOPMENT founded?
GYNECOLOGY SOCIETY DEVELOPMENT was founded on 03-11-2008.
Is GYNECOLOGY SOCIETY DEVELOPMENT still active?
Yes, GYNECOLOGY SOCIETY DEVELOPMENT is an active enterprise in the KBO register.
How many employees does GYNECOLOGY SOCIETY DEVELOPMENT have?
GYNECOLOGY SOCIETY DEVELOPMENT had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of GYNECOLOGY SOCIETY DEVELOPMENT?
The turnover in financial year 2025 is about €110,000. This figure is estimated from the gross margin of €34,411 and 47 comparable companies (NACE 86). It probably lies between €76,000 and €150,000.
Is GYNECOLOGY SOCIETY DEVELOPMENT profitable?
In financial year 2025, GYNECOLOGY SOCIETY DEVELOPMENT made a profit of €3,111.
Where can I find the annual accounts of GYNECOLOGY SOCIETY DEVELOPMENT?
GYNECOLOGY SOCIETY DEVELOPMENT filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of GYNECOLOGY SOCIETY DEVELOPMENT due?
GYNECOLOGY SOCIETY DEVELOPMENT must file the annual accounts for financial year 2026 by 31-05-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.